Due to the rescheduling of the RXIX conference, we are re-opening the
call for abstracts and repeating the abstract selection process afresh.
To be considered for the rescheduled conference dates in 2021,
submitters will have the opportunity either (a) to submit completely
new abstracts or (b) to update and resubmit their original abstracts.
Once you login to the conference website, you will be able to
view abstracts that you submitted for the original conference dates and
can edit and resubmit them. Abstracts
submitted previously will not be automatically considered for the 2021
conference unless they are resubmitted.
The theme for RXIX is "Past,
Present, Future", and we will aim to highlight
past achievements that are part of our foundation, focus on
cutting-edge solutions for present challenges and look to build a
roadmap together to enable the future. The RXIX conference will bring
together leading scientists and engineers from industry, academia and
regulatory authorities that are actively engaged in the purification of
diverse biotherapeutic modalities.
Updated session topics and descriptions
are available on the website. Please use these descriptions to
pre-select a session where you believe your work fits best. Abstracts
not selected for one of the limited oral presentation slots will be
considered for a poster presentation.
Abstracts (one page maximum) that include specific results and
conclusions to allow a scientific assessment of proposed oral presentation
or poster are invited.
and poster) submission deadline: 15 January 2021
We thank you for your interest and look forward to your presence at
this exciting conference in July 2021. We can’t wait to be together
Best wishes The RXIX
Co-Chairs Suzy Farid (UCL, UK), Nihal Tugcu(Sanofi, USA), Arne Staby(Novo Nordisk,
"Integrating science and technology to add value and contain costs"